|
KIAA0495 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.079600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.180100E-04 |
| Normal-vs-Stage2 |
3.012000E-01 |
| Normal-vs-Stage3 |
5.244800E-01 |
| Normal-vs-Stage4 |
3.327800E-01 |
| Stage1-vs-Stage2 |
1.349560E-01 |
| Stage1-vs-Stage3 |
5.464400E-03 |
| Stage1-vs-Stage4 |
6.21929999999882E-05 |
| Stage2-vs-Stage3 |
5.914400E-01 |
| Stage2-vs-Stage4 |
8.082100E-02 |
| Stage3-vs-Stage4 |
1.393560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.662300E-02 |
| Normal-vs-AfricanAmerican |
4.043400E-03 |
| Normal-vs-Asian |
8.527700E-02 |
| Caucasian-vs-AfricanAmerican |
1.646130E-02 |
| Caucasian-vs-Asian |
6.860200E-02 |
| AfricanAmerican-vs-Asian |
4.828800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.671580E-01 |
| Normal-vs-Female |
5.829500E-04 |
| Male-vs-Female |
1.143530E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.173800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.455200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.263440E-01 |
| Normal-vs-Age(81-100Yrs) |
6.982200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.999000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.828600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.892000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.276420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.198200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.689000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.63069999995036E-06 |
| Normal-vs-Grade 2 |
1.828190E-04 |
| Normal-vs-Grade 3 |
3.648600E-01 |
| Normal-vs-Grade 4 |
1.596160E-01 |
| Grade 1-vs-Grade 2 |
3.736500E-02 |
| Grade 1-vs-Grade 3 |
1.760390E-04 |
| Grade 1-vs-Grade 4 |
2.47919999999402E-05 |
| Grade 2-vs-Grade 3 |
8.165500E-04 |
| Grade 2-vs-Grade 4 |
2.01839999999232E-05 |
| Grade 3-vs-Grade 4 |
1.976500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.787850E-04 |
| Normal-vs-ccB subtype |
3.023200E-01 |
| ccA subtype-vs-ccB subtype |
8.056100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.019900E-02 |
| Normal-vs-N1 |
7.051200E-01 |
| N0-vs-N1 |
7.314600E-01 |
|
|
